Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew Revision: v3.3.3 appears on the page, and the footer no longer shows 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. This is a minor site maintenance update that does not affect study data or page content.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedNew revision entry v3.3.2 was added and v3.2.0 was removed from the page history. This does not modify any study data or displayed content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe top-of-page government funding/status notice was removed. It previously warned that data may not be up to date and inquiries may be delayed.SummaryDifference0.5%

- Check68 days agoChange DetectedA new version entry (Version 26, submitted 2025-08-12) appears in the history, reflecting updated study status and recruitment details for NCT05516498.SummaryDifference0.1%

- Check90 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference11%

- Check97 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.